These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30566019)

  • 1. Myocardial Revascularization Trials.
    Ruel M; Falk V; Farkouh ME; Freemantle N; Gaudino MF; Glineur D; Cameron DE; Taggart DP
    Circulation; 2018 Dec; 138(25):2943-2951. PubMed ID: 30566019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revascularization options: coronary artery bypass surgery and percutaneous coronary intervention.
    Kappetein AP; van Mieghem NM; Head SJ
    Cardiol Clin; 2014 Aug; 32(3):457-61. PubMed ID: 25091970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
    Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
    JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it time to change how we think about incomplete coronary revascularization?
    Spadaccio C; Nappi F; Nenna A; Beattie G; Chello M; Sutherland FW
    Int J Cardiol; 2016 Dec; 224():295-298. PubMed ID: 27665400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.
    Burgess SN; Mussap CJ; French JK
    Clin Ther; 2013 Aug; 35(8):1069-75. PubMed ID: 23973040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Inflammatory Responses Between Robotically Enhanced Coronary Artery Bypass Grafting and Conventional Coronary Artery Bypass Grafting: Implications for Hybrid Revascularization.
    Leyvi G; Vivek K; Sehgal S; Warrick A; Moncada KA; Shilian N; Leff JD; Michler RE; DeRose JJ
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):251-258. PubMed ID: 28807577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid coronary revascularization for treatment of multivessel coronary artery disease.
    Hu S
    Eur Heart J; 2014 Oct; 35(38):2624-5. PubMed ID: 25422839
    [No Abstract]   [Full Text] [Related]  

  • 9. Reviewing hybrid coronary revascularization: challenges, controversies and opportunities.
    Kayatta MO; Halkos ME
    Expert Rev Cardiovasc Ther; 2016 Jul; 14(7):821-30. PubMed ID: 27042753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
    Giustino G; Mehran R; Serruys PW; Sabik JF; Milojevic M; Simonton CA; Puskas JD; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Généreux P; Zhang Z; McAndrew T; Redfors B; Ragosta M; Kron IL; Dressler O; Leon MB; Pocock SJ; Ben-Yehuda O; Kappetein AP; Stone GW
    J Am Coll Cardiol; 2018 Aug; 72(7):754-765. PubMed ID: 30092952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous or surgical revascularization for left main stem disease: NOBLE ideas, but do they EXCEL?
    Kassimis G; Raina T; Kontogiannis N; Krasopoulos G; Gunn J
    Expert Rev Cardiovasc Ther; 2019 May; 17(5):361-368. PubMed ID: 31088173
    [No Abstract]   [Full Text] [Related]  

  • 12. Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.
    Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28607000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.
    Sipahi I; Akay MH; Dagdelen S; Blitz A; Alhan C
    JAMA Intern Med; 2014 Feb; 174(2):223-30. PubMed ID: 24296767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid coronary revascularization by endoscopic robotic coronary artery bypass grafting on beating heart and stent placement.
    Gao C; Yang M; Wu Y; Wang G; Xiao C; Liu H; Lu C
    Ann Thorac Surg; 2009 Mar; 87(3):737-41. PubMed ID: 19231382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical versus percutaneous revascularization in patients with multivessel coronary artery disease.
    Davierwala PM; Mohr FW
    Curr Atheroscler Rep; 2014 Dec; 16(12):461. PubMed ID: 25344743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial revascularization strategies in diabetic patients with multi-vessel disease: CABG vs DES-based PCI.
    Kassimis G; Patel N; Banning AP
    Curr Pharm Des; 2014; 20(28):4589-96. PubMed ID: 24568733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ESC/EACTS guidelines on myocardial revascularization 2018 : The most important innovations].
    Neumann FJ; Hochholzer W; Siepe M
    Herz; 2018 Dec; 43(8):689-694. PubMed ID: 30456630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally Invasive Multivessel Coronary Surgery and Hybrid Coronary Revascularization: Can We Routinely Achieve Less Invasive Coronary Surgery?
    Rodriguez M; Ruel M
    Methodist Debakey Cardiovasc J; 2016; 12(1):14-9. PubMed ID: 27127557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.